Perihilar Biliary Neuroendocrine Carcinoma Treated With Perioperative Chemotherapy and Radical Liver Surgery: A Thought-Provoking Case
American Journal of Case Reports · 2026
DOI: 10.12659/ajcr.951108 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2026. Verfasst von Ryo Ataka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Otsu Red Cross Hospital, Otsu, Shiga, Japan. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Hepatectomy, Bile Duct Neoplasms, Bile Ducts, Extrahepatic. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Otsu Red Cross Hospital, Otsu, Shiga, Japan.
- Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Surgery, Uji-Tokushukai Medical Center, Kyoto, Japan.
- Department of Surgery, Ichinomiyanishi Hospital, Ichinomiya, Aichi, Japan.
ORCID-Profile: Ryo Ataka
Zitieren
APA
Ataka, R., Kitaguchi, K., Nakayama, Y., Ikeno, Y., Toyoda, E., & Hirose, T. (2026). Perihilar Biliary Neuroendocrine Carcinoma Treated With Perioperative Chemotherapy and Radical Liver Surgery: A Thought-Provoking Case. American Journal of Case Reports. https://doi.org/10.12659/ajcr.951108
Vancouver
Ataka R, Kitaguchi K, Nakayama Y, Ikeno Y, Toyoda E, Hirose T. Perihilar Biliary Neuroendocrine Carcinoma Treated With Perioperative Chemotherapy and Radical Liver Surgery: A Thought-Provoking Case. American Journal of Case Reports. 2026. doi:10.12659/ajcr.951108
BibTeX
@article{Ataka2026,
author = {Ataka, Ryo and Kitaguchi, Kazuhiko and Nakayama, Yusuke and Ikeno, Yoshinobu and Toyoda, Eiji and Hirose, Tetsuro},
title = {Perihilar Biliary Neuroendocrine Carcinoma Treated With Perioperative Chemotherapy and Radical Liver Surgery: A Thought-Provoking Case},
journal = {American Journal of Case Reports},
year = {2026},
doi = {10.12659/ajcr.951108}
}
EUVIMED